The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Gastrointestinal Therapeutics-Global Market Insights and Sales Trends 2024
Synopsis
Gastrointestinal disorders are medical conditions related to the digestive system that affect the colon, small & large intestine, and rectum. The disorders mainly include constipation, peptic ulcer diseases, and irritable bowel syndrome characterized by various symptoms such as pain, bloating, diarrhea, nausea, and vomiting. Gastrointestinal therapeutics includes drugs, which are commercially available in the market namely Aciphex, Afinitor, Akynzeo, Dificid, and Prilosec.
The global Gastrointestinal Therapeutics market size is expected to reach US$ 50460 million by 2029, growing at a CAGR of 5.3% from 2023 to 2029. The market is mainly driven by the significant applications of Gastrointestinal Therapeutics in various end use industries. The expanding demands from the IBD and Irritable Bowel Syndrome (IBS), are propelling Gastrointestinal Therapeutics market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Parenteral segment is estimated at % CAGR for the next seven-year period.
Accounting for more than 80% of the total market shares, the IBD disease market segment dominated the market. IBD involves a group of autoimmune diseases such as Crohn's disease and ulcerative colitis and is expected to grow at a CAGR of more than 4.3% in the next few years.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Gastrointestinal Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Gastrointestinal Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Gastrointestinal Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Gastrointestinal Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Gastrointestinal Therapeutics covered in this report include AbbVie, Allergan, Johnson & Johnson, Takeda, Novartis, Pfizer, Merck, F. Hoffmann-La Roche and Eli Lilly, etc.
The global Gastrointestinal Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AbbVie
Allergan
Johnson & Johnson
Takeda
Novartis
Pfizer
Merck
F. Hoffmann-La Roche
Eli Lilly
AstraZeneca
Procter & Gamble
Tillotts Pharma
Takeda
GlaxoSmithKline
Amgen
Global Gastrointestinal Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Gastrointestinal Therapeutics market, Segment by Type:
Oral
Parenteral
Global Gastrointestinal Therapeutics market, by Application
IBD
Irritable Bowel Syndrome (IBS)
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Gastrointestinal Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Gastrointestinal disorders are medical conditions related to the digestive system that affect the colon, small & large intestine, and rectum. The disorders mainly include constipation, peptic ulcer diseases, and irritable bowel syndrome characterized by various symptoms such as pain, bloating, diarrhea, nausea, and vomiting. Gastrointestinal therapeutics includes drugs, which are commercially available in the market namely Aciphex, Afinitor, Akynzeo, Dificid, and Prilosec.
The global Gastrointestinal Therapeutics market size is expected to reach US$ 50460 million by 2029, growing at a CAGR of 5.3% from 2023 to 2029. The market is mainly driven by the significant applications of Gastrointestinal Therapeutics in various end use industries. The expanding demands from the IBD and Irritable Bowel Syndrome (IBS), are propelling Gastrointestinal Therapeutics market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Parenteral segment is estimated at % CAGR for the next seven-year period.
Accounting for more than 80% of the total market shares, the IBD disease market segment dominated the market. IBD involves a group of autoimmune diseases such as Crohn's disease and ulcerative colitis and is expected to grow at a CAGR of more than 4.3% in the next few years.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Gastrointestinal Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Gastrointestinal Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Gastrointestinal Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Gastrointestinal Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Gastrointestinal Therapeutics covered in this report include AbbVie, Allergan, Johnson & Johnson, Takeda, Novartis, Pfizer, Merck, F. Hoffmann-La Roche and Eli Lilly, etc.
The global Gastrointestinal Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AbbVie
Allergan
Johnson & Johnson
Takeda
Novartis
Pfizer
Merck
F. Hoffmann-La Roche
Eli Lilly
AstraZeneca
Procter & Gamble
Tillotts Pharma
Takeda
GlaxoSmithKline
Amgen
Global Gastrointestinal Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Gastrointestinal Therapeutics market, Segment by Type:
Oral
Parenteral
Global Gastrointestinal Therapeutics market, by Application
IBD
Irritable Bowel Syndrome (IBS)
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Gastrointestinal Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Gastrointestinal Therapeutics
1.1 Gastrointestinal Therapeutics Market Overview
1.1.1 Gastrointestinal Therapeutics Product Scope
1.1.2 Gastrointestinal Therapeutics Market Status and Outlook
1.2 Global Gastrointestinal Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Gastrointestinal Therapeutics Market Size by Region (2018-2029)
1.4 Global Gastrointestinal Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Gastrointestinal Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Gastrointestinal Therapeutics Market Size (2018-2029)
1.6.1 North America Gastrointestinal Therapeutics Market Size (2018-2029)
1.6.2 Europe Gastrointestinal Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Gastrointestinal Therapeutics Market Size (2018-2029)
1.6.4 Latin America Gastrointestinal Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Gastrointestinal Therapeutics Market Size (2018-2029)
2 Gastrointestinal Therapeutics Market by Type
2.1 Introduction
2.1.1 Oral
2.1.2 Parenteral
2.2 Global Gastrointestinal Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Gastrointestinal Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Gastrointestinal Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Gastrointestinal Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Gastrointestinal Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Gastrointestinal Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Gastrointestinal Therapeutics Revenue Breakdown by Type (2018-2029)
3 Gastrointestinal Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 IBD
3.1.2 Irritable Bowel Syndrome (IBS)
3.2 Global Gastrointestinal Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Gastrointestinal Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Gastrointestinal Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Gastrointestinal Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Gastrointestinal Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Gastrointestinal Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Gastrointestinal Therapeutics Revenue Breakdown by Application (2018-2029)
4 Gastrointestinal Therapeutics Competition Analysis by Players
4.1 Global Gastrointestinal Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics as of 2022)
4.3 Date of Key Players Enter into Gastrointestinal Therapeutics Market
4.4 Global Top Players Gastrointestinal Therapeutics Headquarters and Area Served
4.5 Key Players Gastrointestinal Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Gastrointestinal Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 AbbVie
5.1.1 AbbVie Profile
5.1.2 AbbVie Main Business
5.1.3 AbbVie Gastrointestinal Therapeutics Products, Services and Solutions
5.1.4 AbbVie Gastrointestinal Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 AbbVie Recent Developments
5.2 Allergan
5.2.1 Allergan Profile
5.2.2 Allergan Main Business
5.2.3 Allergan Gastrointestinal Therapeutics Products, Services and Solutions
5.2.4 Allergan Gastrointestinal Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Allergan Recent Developments
5.3 Johnson & Johnson
5.3.1 Johnson & Johnson Profile
5.3.2 Johnson & Johnson Main Business
5.3.3 Johnson & Johnson Gastrointestinal Therapeutics Products, Services and Solutions
5.3.4 Johnson & Johnson Gastrointestinal Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Takeda Recent Developments
5.4 Takeda
5.4.1 Takeda Profile
5.4.2 Takeda Main Business
5.4.3 Takeda Gastrointestinal Therapeutics Products, Services and Solutions
5.4.4 Takeda Gastrointestinal Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Takeda Recent Developments
5.5 Novartis
5.5.1 Novartis Profile
5.5.2 Novartis Main Business
5.5.3 Novartis Gastrointestinal Therapeutics Products, Services and Solutions
5.5.4 Novartis Gastrointestinal Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Novartis Recent Developments
5.6 Pfizer
5.6.1 Pfizer Profile
5.6.2 Pfizer Main Business
5.6.3 Pfizer Gastrointestinal Therapeutics Products, Services and Solutions
5.6.4 Pfizer Gastrointestinal Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Pfizer Recent Developments
5.7 Merck
5.7.1 Merck Profile
5.7.2 Merck Main Business
5.7.3 Merck Gastrointestinal Therapeutics Products, Services and Solutions
5.7.4 Merck Gastrointestinal Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Merck Recent Developments
5.8 F. Hoffmann-La Roche
5.8.1 F. Hoffmann-La Roche Profile
5.8.2 F. Hoffmann-La Roche Main Business
5.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Products, Services and Solutions
5.8.4 F. Hoffmann-La Roche Gastrointestinal Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 F. Hoffmann-La Roche Recent Developments
5.9 Eli Lilly
5.9.1 Eli Lilly Profile
5.9.2 Eli Lilly Main Business
5.9.3 Eli Lilly Gastrointestinal Therapeutics Products, Services and Solutions
5.9.4 Eli Lilly Gastrointestinal Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 Eli Lilly Recent Developments
5.10 AstraZeneca
5.10.1 AstraZeneca Profile
5.10.2 AstraZeneca Main Business
5.10.3 AstraZeneca Gastrointestinal Therapeutics Products, Services and Solutions
5.10.4 AstraZeneca Gastrointestinal Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 AstraZeneca Recent Developments
5.11 Procter & Gamble
5.11.1 Procter & Gamble Profile
5.11.2 Procter & Gamble Main Business
5.11.3 Procter & Gamble Gastrointestinal Therapeutics Products, Services and Solutions
5.11.4 Procter & Gamble Gastrointestinal Therapeutics Revenue (US$ Million) & (2018-2023)
5.11.5 Procter & Gamble Recent Developments
5.12 Tillotts Pharma
5.12.1 Tillotts Pharma Profile
5.12.2 Tillotts Pharma Main Business
5.12.3 Tillotts Pharma Gastrointestinal Therapeutics Products, Services and Solutions
5.12.4 Tillotts Pharma Gastrointestinal Therapeutics Revenue (US$ Million) & (2018-2023)
5.12.5 Tillotts Pharma Recent Developments
5.13 Takeda
5.13.1 Takeda Profile
5.13.2 Takeda Main Business
5.13.3 Takeda Gastrointestinal Therapeutics Products, Services and Solutions
5.13.4 Takeda Gastrointestinal Therapeutics Revenue (US$ Million) & (2018-2023)
5.13.5 Takeda Recent Developments
5.14 GlaxoSmithKline
5.14.1 GlaxoSmithKline Profile
5.14.2 GlaxoSmithKline Main Business
5.14.3 GlaxoSmithKline Gastrointestinal Therapeutics Products, Services and Solutions
5.14.4 GlaxoSmithKline Gastrointestinal Therapeutics Revenue (US$ Million) & (2018-2023)
5.14.5 GlaxoSmithKline Recent Developments
5.15 Amgen
5.15.1 Amgen Profile
5.15.2 Amgen Main Business
5.15.3 Amgen Gastrointestinal Therapeutics Products, Services and Solutions
5.15.4 Amgen Gastrointestinal Therapeutics Revenue (US$ Million) & (2018-2023)
5.15.5 Amgen Recent Developments
6 North America
6.1 North America Gastrointestinal Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Gastrointestinal Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Gastrointestinal Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Gastrointestinal Therapeutics Market Dynamics
11.1 Gastrointestinal Therapeutics Industry Trends
11.2 Gastrointestinal Therapeutics Market Drivers
11.3 Gastrointestinal Therapeutics Market Challenges
11.4 Gastrointestinal Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
